Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Kwong

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Clinics in Liver Disease|May 12, 2021
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma: Is There a Limit?Allison Kwong, Neil Mehta
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 25, 2022
CAQ Corner: Disease recurrence after liver transplantationAparna Goel, Allison Kwong
Gastroenterology|January 22, 2022
ReplyAllison Kwong, W Ray Kim
Current Opinion in Organ Transplantation|June 20, 2023
Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratificationJoshua Norman, Neil Mehta, Allison Kwong
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 10, 2019
Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease"Allison Kwong, Ajitha Mannalithara, W Ray Kim
Journal of Vascular and Interventional Radiology : JVIR|February 22, 2023
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant CandidatesXiao Wu, Michael Heller, Allison Kwong, et al.
Plos One|December 29, 2018
The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancerKatherine Wong, Katharine Ozeki, Allison Kwong, et al.
JAMA Surgery|October 5, 2022
Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus TreatmentThomas J Handley, Katherine Arnow, Kazunari Sasaki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 10, 2021
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal SyndromeAllison Kwong, W Ray Kim, Paul Y Kwo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 28, 2023
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplantXiao Wu, Allison Kwong, Michael Heller, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Clinics in Liver Disease|May 12, 2021
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma: Is There a Limit?Allison Kwong, Neil Mehta
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 25, 2022
CAQ Corner: Disease recurrence after liver transplantationAparna Goel, Allison Kwong
Gastroenterology|January 22, 2022
ReplyAllison Kwong, W Ray Kim
Current Opinion in Organ Transplantation|June 20, 2023
Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratificationJoshua Norman, Neil Mehta, Allison Kwong
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 10, 2019
Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease"Allison Kwong, Ajitha Mannalithara, W Ray Kim
Journal of Vascular and Interventional Radiology : JVIR|February 22, 2023
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant CandidatesXiao Wu, Michael Heller, Allison Kwong, et al.
Plos One|December 29, 2018
The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancerKatherine Wong, Katharine Ozeki, Allison Kwong, et al.
JAMA Surgery|October 5, 2022
Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus TreatmentThomas J Handley, Katherine Arnow, Kazunari Sasaki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 10, 2021
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal SyndromeAllison Kwong, W Ray Kim, Paul Y Kwo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 28, 2023
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplantXiao Wu, Allison Kwong, Michael Heller, et al.
Pageof 5